Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2579PDF: 738HTML: 2297 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2221PDF: 1046HTML: 1982Characteristic of study group: 198 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2126PDF: 1693HTML: 377 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2452PDF: 784HTML: 1735 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2956PDF: 890HTML: 1947 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1525PDF: 538HTML: 272 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2193PDF: 1488HTML: 266 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3919Suppl. Files: 1115PDF: 1066Html: 176 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2204PDF: 945HTML: 5063Cover Letter: 169Figure 2: 160Figure 1: 173Figure 3: 195Figure 4: 166Figure Legend: 186Table 1: 188Table 2: 180Table 3: 179 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3251PDF: 934HTML: 2954 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2838PDF: 847HTML: 6519Untitled: 226Untitled: 189Untitled: 205Untitled: 210 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7437PDF: 2420HTML: 1732Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3772PDF: 1661HTML: 11590Figures Haase: 198 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3585PDF: 886HTML: 6711 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1043PDF: 1154Suppl. Files: 569HTML: 88 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1182PDF: 752HTML: 1348Figure 1: 186Figure 2: 188 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2016PDF: 758HTML: 3113 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3879PDF: 1475HTML: 8513 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4297PDF: 1372HTML: 2039 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3554PDF: 1067HTML: 874 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1783PDF: 966HTML: 143 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3548PDF: 1571HTML: 80 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1340PDF: 826HTML: 132 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1808PDF: 809HTML: 10234Figures 1,2,3: 173 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1957PDF: 711HTML: 684Table1: patient's characteristics: 155Table 2: profile of each patient: 178







